Arkolith/Insider Trading/RXRX/Form 4

Taylor Ben R

Chief Financial OfficerRECURSION PHARMACEUTICALS, INC. (RXRX) · full profile →Form 4 · filed Dec 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$89K
Net Open-Market Flow
-$89K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2025Sell(S)21K$4.18$89K762K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001712276-25-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML